Pic.: The aim of OPTIMISTIC -- an acronym for Optimizing Patient Transfers, Impacting Medical quality and Improving Symptoms: Transforming Institutional Care -- is to improve care and communication within nursing facilities and between these facilities and acute-care institutions. Credit: Indiana University Center for Aging Research OPTIMISTIC study

Advance care planning in nursing homes challenging but critical

INDIANAPOLIS , Indiana, USA (November 1, 2016) – The goal of advance care planning is to ensure that the health care an individual receives is consistent with his or her values and preferences. New research shows the critical need for advance care planning and highlights the challenges that healthcare institutions — especially nursing homes — face in supporting high quality advance care planning.

The analysis of advance care planning in nursing homes was conducted as part of the OPTIMISTIC project, an initiative developed and implemented at a growing number of nursing homes by a team of clinician-researchers from Indiana University Schools of Nursing and Medicine and the Regenstrief Institute.

The aim of OPTIMISTIC — an acronym for Optimizing Patient Transfers, Impacting Medical quality and Improving Symptoms: Transforming Institutional Care — is to improve care and communication within nursing facilities and between these facilities and acute-care institutions. The goal is to catch and solve problems early, improving quality of care and reducing unnecessary hospital transfers.

"An Interim Analysis of an Advance Care Planning Intervention in the Nursing Home Setting" is available online ahead of print publication in the Journal of the American Geriatrics Society. The goal of the study was to describe the implementation of advance care planning in nursing homes. The study emphasizes the importance of resident preferences when trying to reduce avoidable hospitalizations of nursing home residents.

The researchers reported on the formal advance care planning conversations facilitated by specially trained nurses with residents and family members in the 19 nursing homes participating in the initial phase of OPTIMISTIC. These conversations resulted in changes in care plans about two-thirds of the time.

When asked, many nursing home residents (or family members of those unable to make decisions for themselves) preferred less aggressive treatment than the default of providing all available treatments to the often frail and chronically ill residents.

Significantly, almost half of those residents or family members who participated in advance care planning as a part of the OPTIMISTIC study elected only comfort care rather than potentially life extending measures like going to the intensive care unit.

Only six percent of nursing home residents who were asked to participate in an advance care conversation declined to do so.

"Implementation of advance care planning in the nursing home setting has not been well studied," said JAGS study first author Susan Hickman, PhD, professor at IU School of Nursing and an IU Center for Aging Research affiliated scientist. "Supporting high quality advance care planning takes significant time and resources such as staff training, policy changes, and education. Encouragingly, we found that most residents and family members want to talk about treatment preferences and that these conversations often result in changes in our understanding of resident’s goals." Dr. Hickman is a geriatric psychologist.

During the study the average length of advance care planning conversations was approximately 40 minutes. Many residents had more than one conversation on the topic.

The Centers for Disease Control and Prevention recommends that advance care planning be part of the self-management approach to living with multiple chronic diseases, typical of many older adults. The Institute of Medicine has identified advance care planning as a key strategy to improving care of patients near the end of life.

"Advance care planning and learning the goals of care from patients and families is the cornerstone for providing excellent palliative care to people with serious illnesses, including frail residents of nursing homes, many of whom have advanced dementia," said Greg Sachs, MD, senior author of the JAGS study. "If a patient and family want to aim at remaining comfortable in the nursing facility and forgoing a burdensome transfer and non-beneficial treatments in the hospital, we need to know that so that their care matches these goals.

"This is why Medicare now pays physicians to hold advance care planning conversations, and why we are continuing to strengthen our advance care planning intervention in OPTIMISTIC and have added a palliative care nurse to support advance care planning implementation and symptom management to the program for phase II." Dr. Sachs is a Regenstrief Institute investigator, and professor of medicine and director of the Division of General Internal Medicine and Geriatrics at IU School of Medicine. He co-directed Phase I of OPTIMISTIC.

In addition to Dr. Hickman and Dr. Sachs, co-authors of the JAGS study are Kathleen Unroe, MD, MHA of the IU Center for Aging Research, the Regenstrief Institute and IU School of Medicine; Bryce Buente, formerly of the IU Center for Aging Research and the Regenstrief Institute; Mary Ersek, PhD, of the University of Pennsylvania School of Nursing and Arif Nazir, MD, formerly with IU School of Medicine and now with Signature HealthCARE.

OPTIMISTIC is expected to receive more than $30 million of Centers for Medicare and Medicaid Services funding through The Initiative to Reduce Avoidable Hospitalizations among Nursing Facility Residents. This includes $16.9 million awarded earlier this year for the second phase of OPTIMISTIC, led by Dr. Unroe.

Pic.: The aim of OPTIMISTIC — an acronym for Optimizing Patient Transfers, Impacting Medical quality and Improving Symptoms: Transforming Institutional Care — is to improve care and communication within nursing facilities and between these facilities and acute-care institutions. Credit: Indiana University Center for Aging Research


Indiana University , 01.11.2016 (tB)

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…